EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.4.24.18 | Acute Kidney Injury |
7695599 |
The role of meprin A in the pathogenesis of acute renal failure. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
3
4
0 |
| 3.4.24.18 | Acute Kidney Injury |
17377510 |
Role of meprin A in renal tubular epithelial cell injury. |
ongoing research
unassigned |
4
0 |
| 3.4.24.18 | Acute Kidney Injury |
18093581 |
Actinonin, a meprin inhibitor, protects ischemic acute kidney injury in male but not in female rats. |
causal interaction
ongoing research
unassigned |
4
4
0 |
| 3.4.24.18 | Acute Kidney Injury |
18971209 |
Meprin A metalloproteases enhance renal damage and bladder inflammation after LPS challenge. |
causal interaction
ongoing research
therapeutic application
unassigned |
3
3
3
0 |
| 3.4.24.18 | Acute Kidney Injury |
23427141 |
Meprin A metalloproteinase and its role in acute kidney injury. |
causal interaction
diagnostic usage
unassigned |
4
2
0 |
| 3.4.24.18 | Acute Kidney Injury |
24662289 |
ADAM10 is the major sheddase responsible for the release of membrane-associated meprin A. |
causal interaction
ongoing research
unassigned |
4
3
0 |
| 3.4.24.18 | Acute Kidney Injury |
32174142 |
Meprin ? Activity Modulates the beta Catalytic Subunit of Protein Kinase A (PKA C?) in Ischemia/Reperfusion-Induced Acute Kidney Injury. |
ongoing research
unassigned |
1
0 |
| 3.4.24.18 | Acute Lung Injury |
31020584 |
Inhibition of Meprins Reduces Pulmonary Edema in LPS-Induced Acute Lung Damage. |
causal interaction
ongoing research
unassigned |
2
3
0 |
| 3.4.24.18 | Adenocarcinoma, Mucinous |
16822880 |
Low meprin alpha expression differentiates primary ovarian mucinous carcinoma from gastrointestinal cancers that commonly metastasise to the ovaries. |
causal interaction
diagnostic usage
ongoing research
unassigned |
2
4
4
0 |
| 3.4.24.18 | Alopecia |
34508852 |
Syndecan-1 shedding by meprin ? impairs keratinocyte adhesion and differentiation in hyperkeratosis. |
therapeutic application
unassigned |
1
0 |
